Overview Rating

Speculative

Technicals Analysis

0100

Financials Analysis

0100

MiMedx Group (NASDAQ:MDXG) Stock Quotes, Forecast and News Summary

Q: What sector and industry does MiMedx Group (MDXG) operate in?

MiMedx Group is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

MiMedx Group Stock (NASDAQ: MDXG) stock price, news, charts, stock research, profile.

Open	$6.93
Close	-
Volume / Avg.	231.75K / 803.79K
Day Range	6.71 - 7.01
52 Wk Range	5.57 - 9.27
Market Cap	$1.00B
P/E Ratio	12.88
Dividend Yield	-
Exchange	NASDAQ
RSI	43
Short Interest	4.74%
Days to Cover	9.72

Recent News

Rivian Automotive Reports Weak Delivery Figures, Joins JOYY, MiMedx Group And Other Big Stocks Moving Lower On Tuesday

U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 200 points on Tuesday.

Avi Kapoor

Chipotle, Amazon, Deckers Outdoor, Capital One And Other Stocks Move Higher On Friday

U.S. stocks traded mixed, with the Nasdaq Composite gaining more than 100 points on Friday. Here are some big stocks recording gains in today’s session.

Lisa Levin

MiMedx Targets Profitability with Strategic Realignment, Suspends Knee Osteoarthritis Program Activities

MiMedx Group Inc (NASDAQ: MDXG) announced a strategic realignment to focus its resources on its Wound & Surgical business, driving profitability and

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Mar

May

Jul

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Mimedx Group Inc

Sector

Health Care

Industry

Biotechnology

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from th...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy MiMedx Group (MDXG) stock?

You can purchase shares of MiMedx Group (NASDAQ:MDXG) through any online brokerage.

View our list of the best stock brokerages

Who are MiMedx Group (MDXG) competitors?

Other companies in MiMedx Group’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), Gyre Therapeutics (NASDAQ:GYRE), 4D Molecular Therapeutics (NASDAQ:FDMT), Cogent Biosciences (NASDAQ:COGT) and Centessa Pharmaceuticals (NASDAQ:CNTA).

What is the target price for MiMedx Group (MDXG) stock?

There is no analysis for MiMedx Group.

What is the forecast for MiMedx Group (MDXG) stock?

MiMedx Group has a consensus price target of $13.83.

Current stock price for MiMedx Group (MDXG)?

The stock price for MiMedx Group (NASDAQ: MDXG) is $6.78 last updated Today at July 2, 2024 at 1:04 PM EDT.

Does MiMedx Group (MDXG) pay a dividend?

There are no upcoming dividends for MiMedx Group.

When is MiMedx Group (NASDAQ:MDXG) reporting earnings?

MiMedx Group’s Q2 earnings are confirmed for Tuesday, July 30, 2024.

Is MiMedx Group (MDXG) going to split?

There is no upcoming split for MiMedx Group.

What sector and industry does MiMedx Group (MDXG) operate in?

MiMedx Group is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

MiMedx Group

MiMedx Group (MDXG) Forecast